UTI Small Cap Fund
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of small cap companies.
Growthvine rating: 2/5 — ranked #19 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹27.92 (as of 2026-08-21) |
|---|
| AUM | ₹5,263 Cr |
|---|
| Expense ratio | 1.59% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Nitin Jain |
|---|
| Exit load | 1% for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 14.47% |
|---|
| Sharpe ratio | 0.49 |
|---|
| Standard deviation | 19.64% |
|---|
| Max drawdown | -22.54% |
|---|
| Alpha | -0.43 |
|---|
| Beta | 0.88 |
|---|
Over 5 years, captured 80.6% of NIFTY Smallcap 250's upside and 74.3% of its downside.
Market cap allocation
| Large cap | 0.0% |
|---|
| Mid cap | 18.5% |
|---|
| Small cap | 81.5% |
|---|
Concentration
| Top 5 holdings | 11.7% |
|---|
| Top 10 holdings | 20.3% |
|---|
| Total holdings | 107 |
|---|
| Index overlap | 23.7% |
|---|
| Active share | 76.3% |
|---|
Top holdings
- NET CURRENT ASSETS — 3.9%
- Karur Vysya Bank Ltd. — 2.5%
- Ujjivan Small Finance Bank Limited — 2.4%
- ACUTAAS CHEMICALS LIMITED — 2.4%
- Navin Fluorine International Limited — 2.3%
- Aster DM Healthcare Limited — 2.2%
- Delhivery Limited — 1.8%
- AFFLE 3I LIMITED — 1.7%
- Caplin Point Laboratories Ltd. — 1.7%
- City Union Bank Ltd — 1.7%
Top sectors
- Banking & Financial — 10.7%
- Pharma & Biotech — 10.1%
- Industrial Products — 9.2%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 10.2% | Q4 (Bottom) | #27 of 34 |
| 2025 | -5.3% | Q3 | #21 of 30 |
| 2024 | 26.8% | Q2 | #10 of 28 |
| 2023 | 35.3% | Q3 | #18 of 24 |
| 2022 | -0.6% | Q3 | #12 of 22 |